🇺🇸 REZIPAS in United States

REZIPAS (AMINOSALICYLIC ACID RESIN COMPLEX) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: NDA009052
  • Marketing authorisation holder: BRISTOL MYERS SQUIBB
  • Local brand name: REZIPAS
  • Indication: POWDER — ORAL
  • Status: approved

Read official source →

REZIPAS in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is REZIPAS approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for REZIPAS in United States?

BRISTOL MYERS SQUIBB is the originator. The local marketing authorisation holder may differ — check the official source linked above.